Climate Change Data

C.H. Boehringer Sohn AG & Co. KG

Climate Impact & Sustainability Data (2020, 2023)

Reporting Period: 2020

Environmental Metrics

Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed

ESG Focus Areas

  • More Health
  • More Potential
  • More Green

Environmental Achievements

  • Launched "BE GREEN – Future by Choice" program with global goals for 2030, focusing on reducing CO2 emissions, using renewable energy, reducing waste, and creating environmentally friendly products.
  • Xochimilco (Mexico) production facility received Alliance Water Stewardship (AWS) certification.

Social Achievements

  • Established the "Angels Initiative" to optimize stroke care, creating a network of over 4,300 clinics worldwide.
  • Launched the "LastMile" initiative to improve access to veterinary medicine in sub-Saharan Africa, including a new mobile app for better management and data collection.
  • Making More Health (MMH) initiative reached approximately 9.3 million people worldwide.
  • Published and executed the first action plan in Germany for implementation of the UN Convention on the Rights of Persons with Disabilities 2012-2020.
  • Enabled all employees to take up to 10 days of fully paid leave to volunteer with external organizations in the fight against COVID-19.

Governance Achievements

  • Not disclosed

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Not disclosed
Short-term Goals:
  • Not disclosed

Environmental Challenges

  • COVID-19 pandemic impacting global economic output, trade, and investment.
  • Price pressure for pharmaceuticals in core markets.
  • Increased efforts to shift payment burden onto patients.
  • Protection of intellectual property under pressure.
  • COVID-19-related logistical challenges impacting production and supply chains.
  • Declining sales in some livestock segments due to COVID-19 measures.
  • Production and supply bottlenecks due to COVID-19 pandemic.
Mitigation Strategies
  • Implemented measures to minimize the impact of the COVID-19 pandemic on employees, patients, and society.
  • Safeguarded production and supply of medicines and veterinary pharmaceuticals.
  • Expanded digital customer relations strategies.
  • Implemented risk-mitigating measures to counter COVID-19-specific threats to production activities (physical segregation of teams, mask mandates, increased disinfectant supply, employee testing, work-from-home options).
  • Implemented measures to guarantee reliable and high-quality supplies for internal and external customers.
  • Built up internal standby capacities.

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement
  • Not disclosed

Climate-Related Risks & Opportunities

Physical Risks
  • Not disclosed
Transition Risks
  • Not disclosed
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: Null

Certifications: ISO 14001, ISO 45001, ISO 50001, Alliance Water Stewardship (AWS)

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

  • Not disclosed

Not disclosed

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • Top Employer award from the Top Employers Institute in multiple countries.

Reporting Period: 2023

Environmental Metrics

Renewable Energy Share:70%

ESG Focus Areas

  • Health Equity
  • Environmental Sustainability
  • Social Responsibility
  • Governance

Environmental Achievements

  • Achieved carbon neutrality certification at multiple sites.
  • Increased renewable electricity purchased worldwide to over 70%.
  • Dortmund production site achieved "Zero Waste to Landfill" certification.
  • Reduced packaging waste at Yamagata production site.

Social Achievements

  • Expanded access to healthcare for over 29,000 people through the "Access to Healthcare" initiative.
  • Reached over 400,000 children through the FAST Heroes program.
  • Supported over 130 social entrepreneurs worldwide through the "Making More Health" initiative.
  • 8,625 employees volunteered.

Governance Achievements

  • Implemented a multi-layered governance structure for Human Rights.
  • Published the first Human Rights Policy Statement.
  • Implemented a new third-party risk management process to address Human Rights in the supply chain.

Climate Goals & Targets

Long-term Goals:
  • Provide 500 million rabies vaccine doses and educate 15 million children by 2038.
Medium-term Goals:
  • Become carbon neutral in company operations (Scope 1 and 2) by 2030.
  • Cut resource footprint by half across the value chain by 2030.
  • 100% of R&D projects and products to apply eco-design and green chemistry principles by 2030.
Short-term Goals:
  • Train 2,000 employees to become health and wellbeing ambassadors by 2025.

Environmental Challenges

  • High inflation rates leading to higher energy and production costs.
  • Increasing global institutional efforts to lower the prices of medicinal products.
  • Increasing cost burden on the healthcare system.
  • Geopolitical tensions and conflicts.
Mitigation Strategies
  • Implemented measures to accelerate response to changes, reduce organizational complexity, and optimize cost base.
  • Strategic supplier engagement to reduce Scope 3 emissions.
  • Investing in R&D to drive growth and new product flow.
  • Continuous monitoring and adjustment of costs and business processes.

Supply Chain Management

Responsible Procurement
  • Supplier Code of Conduct
  • PSCI principles

Climate-Related Risks & Opportunities

Physical Risks
  • Natural disasters
Transition Risks
  • Regulatory changes
  • Market shifts
Opportunities
  • Development of sustainable medicines and technologies

Reporting Standards

Frameworks Used: UN Sustainable Development Goals

Certifications: Carbon Neutral Certification, Zero Waste to Landfill Certification, EcoVadis Silver Medal

UN Sustainable Development Goals

  • Goal 3: Good Health and Well-being
  • Goal 13: Climate Action

Initiatives contribute to these goals through improved access to healthcare, reduced environmental footprint, and social engagement.

Sustainable Products & Innovation

  • SENVELGO®
  • NEXGARD® PLUS
  • NEXGARD® COMBO

Awards & Recognition

  • German Sustainability Award
  • EcoVadis Silver Medal
  • Prix Galien USA Best Orphan/Rare Diseases Solution Award